Stock of the Day

September 26, 2019

Afya (AFYA)

$13.90
-$0.26 (-1.8%)
Market Cap: $1.33B

About Afya

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

Today's Trend

Afya Limited (NASDAQ: AFYA) shares appear to be under pressure after a mixed batch of updates from the company and analysts.

  • Afya reported first-quarter 2026 results that modestly beat expectations, with EPS of $0.55 versus the $0.54 consensus and revenue of $194.96 million versus $192.95 million expected. The company also highlighted its quarterly financial results and operating performance. Afya Limited Announces First-Quarter 2026 Financial Results
  • Investors are also weighing additional coverage and commentary around the quarter, including an earnings snapshot and an earnings call transcript/presentation, which generally reinforce attention on the company’s latest operating trends. Afya: Q1 Earnings Snapshot
  • Zacks Research downgraded Afya from “strong-buy” to “hold,” which may have weighed on sentiment by signaling less upside conviction after the earnings release. Zacks.com
  • The bigger offset for shares is Afya’s newly issued FY2026 revenue guidance of $731.7 million to $759.5 million, which sits slightly below the consensus estimate of $760.3 million and suggests a more cautious outlook for the year.

Overall, AFYA is likely moving lower today because the earnings beat was only slight, and weaker-than-expected revenue guidance plus the analyst downgrade appear to be outweighing the positive quarterly results.

← Previous Stock of the DayNext Stock of the Day →